Fabros, Loreta .

HRN: 23-01-67  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2023
CEFTRIAXONE 1G (VIAL)
05/11/2023
05/18/2023
IV
2g
OD
Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: